← FDA Drug Approvals (Drugs@FDA)

POSACONAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: I 3 PHARMS · Approved 2023-08-28

Drug application

FDA Application #

ANDA216488

Application type

Abbreviated New Drug Application (Generic)

Brand name

POSACONAZOLE

Generic name

POSACONAZOLE

Active ingredients

POSACONAZOLE

Dosage form

TABLET, DELAYED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

I 3 PHARMS

Manufacturer

i3 Pharmaceuticals, LLC

First approval

2023-08-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown